Baird raised the firm’s price target on Xylem to $141 from $116 and keeps an Outperform rating on the shares. The firm said backlog/order trends remain healthy, with positive visibility into sustainability such as regulatory trends, IRA/IIJA, internal revenue drivers, end market stability/health.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on XYL:
